Article Details

AstraZeneca announces WAYPOINT trial met both co-primary endpoints - TipRanks.com

Retrieved on: 2024-11-08 14:00:35

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca announces WAYPOINT trial met both co-primary endpoints - TipRanks.com. View article details on hiswai:

Excerpt

Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and Amgen's ...

Article found on: www.tipranks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up